Indivi is a TechBio company developing multi-modal deep phenotyping technologies and derived decision-making biomarkers as drug development tools for neurological diseases for instance in the form of sensor-derived measurements generated from smartphone-based assessments of cognition and motion.



Indivi is committed to developing future-proof and transformative digital endpoints as deep phenotyping instruments to accelerate and de-risk drug development in neurodegenerative disorders such as Parkinson’s disease, multiple sclerosis, Alzheimer’s disease and related dementias.



Indivi is nurturing a unique symbiotic intersection between expert in-house knowledge and experience in clinical development, data science, signal processing engineering, and advanced analytics including computational intelligence.



Through end-to-end collaborative endeavours with biopharmaceutical companies, Indivi is poised to continue its growth to improve the probability of technical and regulatory success in neuroscience drug development.